Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the ...
The Candy Basket Inc. recalled four of its products in California last month due to undeclared allergens, with the U.S. Food and Drug Administration now giving the situation a Class II or Class III ...
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results